Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia

International Journal of Gynecological Cancer

Volumn 16, Issue 5, 2006, Pages 1809-1814

  De Boer, M A ^a   Vet, J N I ^a   Aziz, M F ^b   Cornain, S ^b   Purwoto, G ^b   Van Den Akker, B E W M ^a   Dijkman, A ^a   Peters, A A W ^a   Fleuren, G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Case control study; Cervical cancer; HPV18; Human papillomavirus; Indonesia

Indexed keywords

ADULT; ARTICLE; ASSAY; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INDONESIA; INTERVIEW; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PARITY; PRIORITY JOURNAL; RISK FACTOR; SEXUAL INTERCOURSE; SEXUALITY; UTERINE CERVIX CANCER; VIRUS INFECTION;

ADULT; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; INDONESIA; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33749125005     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00701.x     Document Type: Article

References (20)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3-13.
3. Berumen J, Ordonez RM, Lazcano E et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30.
4. Schellekens MC, Dijkman A, Aziz MF et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 2004;93:49-53.
5. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
6. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
7. Chichareon S, Herrero R, Munoz N et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-7.
8. Franceschi S, Rajkumar T, Vaccarella S et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer 2003;107:127-33.
9. Ngelangel C, Munoz N, Bosch FX et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-9.
10. Hammouda D, Munoz N, Herrero R et al. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer 2005;113:483-9.
11. Shields TS, Brinton LA, Burk RD et al. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus. Cancer Epidemiol Biomarkers Prev 2004;13:1574-82.
12. Jacobs MV, Zielinski D, Meijer CJ et al. A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 2000;82:1421-6.
13. Kleter B, Van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
14. Thomas JO, Herrero R, Omigbodun AA et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638-45.
15. Ferreccio C, Prado RB, Luzoro AV et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004;13:2271-6.
16. Molano M, Posso H, Weiderpass E et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
17. Pham TH, Nguyen TH, Herrero R et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213-20.
18. Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 2005;166:277-97.
19. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
20. Duttagupta C, Sengupta S, Roy M et al. Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer 2004;14:293-303.